Top 10 jaoa.org Wettbewerber

osteopathic.org

The AOA represents more than 207,000 osteopathic physicians and medical students, promotes public health and serves as the primary certifying body for DOs.

medscape.com

today on medscape : get the latest medical news, clinical trial coverage, drug updates, journal articles, cme activities & more on medscape. a free resource for physicians.

anesthesia-analgesia.org

lww journals - beginning with a

instantanatomy.net

Online since 1999, Instant Anatomy is a complete resource for accurate information and learning about human anatomy.

meddean.luc.edu

we are chicago's jesuit catholic university. we are guided by a simple promise: to prepare people to lead extraordinary lives.

ptcentral.com

The online store will allow you to purchase study materials for PT students.

aoa-executivereport.informz.net

informz is a leading provider of digital marketing solutions for associations and nonprofits. email marketing, mobile event app & professional services are our primary offerings.

annfammed.org

PURPOSE Unlike in many community-based settings, benzodiazepine (BZD) prescribing to older veterans has decreased. We sought to identify health care system strategies associated with greater facility-level reductions in BZD prescribing to older adults. METHODS We completed an explanatory sequential mixed methods study of health care facilities in the Veterans Health Administration (N = 140). Among veterans aged ≥75 years receiving long-term BZD treatment, we stratified facilities into relatively high and low performance on the basis of the reduction in average daily dose of prescribed BZD from October 1, 2015 to June 30, 2017. We then interviewed key facility informants (n = 21) who led local BZD reduction efforts (champions), representing 11 high-performing and 6 low-performing facilities. RESULTS Across all facilities, the age-adjusted facility-level average daily dose in October 2015 began at 1.34 lorazepam-equivalent mg/d (SD 0.17); the average rate of decrease was −0.27 mg/d (SD 0.09) per year. All facilities interviewed, regardless of performance, used passive strategies primarily consisting of education regarding appropriate prescribing, alternatives, and identifying potential patients for discontinuation. In contrast, champions at high-performing facilities described leveraging ≥1 active strategies that included individualized recommendations, administrative barriers to prescribing, and performance measures to incentivize clinicians. CONCLUSIONS Initiatives to reduce BZD prescribing to older adults that are primarily limited to passive strategies, such as education and patient identification, might have limited success. Clinicians might benefit from additional recommendations, support, and incentives to modify prescribing practices.